Compare WSBC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WSBC | BHC |
|---|---|---|
| Founded | 1870 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | N/A | N/A |
| Metric | WSBC | BHC |
|---|---|---|
| Price | $34.41 | $7.43 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $39.00 | $8.50 |
| AVG Volume (30 Days) | 528.8K | ★ 1.8M |
| Earning Date | 01-27-2026 | 02-18-2026 |
| Dividend Yield | ★ 4.36% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.04 | 0.97 |
| Revenue | $804,347,000.00 | ★ $10,029,000,000.00 |
| Revenue This Year | $41.89 | $6.81 |
| Revenue Next Year | $13.50 | $4.11 |
| P/E Ratio | $17.05 | ★ $8.03 |
| Revenue Growth | ★ 41.87 | 5.86 |
| 52 Week Low | $26.42 | $4.25 |
| 52 Week High | $37.18 | $8.69 |
| Indicator | WSBC | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 57.30 | 57.38 |
| Support Level | $32.74 | $6.87 |
| Resistance Level | $35.28 | $8.00 |
| Average True Range (ATR) | 0.72 | 0.28 |
| MACD | -0.06 | 0.05 |
| Stochastic Oscillator | 66.54 | 55.95 |
Wesbanco Inc is a bank holding company. Through its subsidiaries, it offers a full range of financial services, including retail banking, corporate banking, personal and corporate trust services, brokerage services, mortgage banking, and insurance. WesBanco operates one commercial bank, WesBanco Bank, which runs scores of branches. The company's reportable segments are Community Banking, which derives key revenue, and Trust and Investment Services. The Community Banking segment offers various banking products and services through various delivery channels, including commercial demand, individual demand, and time deposit accounts; commercial, mortgage, and individual installment loans; and certain non-traditional offerings, such as insurance and securities brokerage services.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.